Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C

Patients with hepatitis C who take tricyclic antidepressants (TCAs) have decreased fibrosis progression and a lower risk of developing cirrhosis, according to results published in the Journal of … Continue reading →

This content was originally published here.

%d bloggers like this: